Home / Journals / CJU / Vol.31, No.1, 2024
Special Issues
  • Open AccessOpen Access

    EDITORIAL

    Perfection is the Enemy of Good and the Imposter Syndrome

    Kevin R. Loughlin
    Canadian Journal of Urology, Vol.31, No.1, pp. 11762-11763, 2024
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    LEGENDS IN UROLOGY

    LEGENDS IN UROLOGY

    Eduardo Solsona Narbón
    Canadian Journal of Urology, Vol.31, No.1, pp. 11764-11766, 2024
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    ARTICLE

    Antibiotic resistance in patients undergoing serial prostate biopsies: risk factors and impact on clinical outcomes

    Alex J. Xu1, Sameer Thakker2, Vyom Sawhney2, Rozalba Gogaj1, Fjolla Vokshi1, James S. Wysock1
    Canadian Journal of Urology, Vol.31, No.1, pp. 11767-11774, 2024
    Abstract Introduction: We evaluate the rate of developing ciprofloxacin resistance in patients undergoing repeat prostate biopsies (PBx), associated risk factors, and impact on complications.
    Materials and methods: We retrospectively evaluated pre-procedural rectal culture (RCx) data in men undergoing PBx from 1/1/2016 to 1/15/2021. Univariate and multivariate logistic regression were utilized to identify risk factors associated with development of antibiotic resistance. Complication rates were compared between ciprofloxacin-sensitive and ciprofloxacin resistant patients.
    Results: A total of 743 men underwent initial RCx. Initial RCx detected ciprofloxacin resistance in 22% of patients. A history of diabetes (p = 0.01), > 2 prior prostate… More >

  • Open AccessOpen Access

    COMMENTARY

    Re: Antibiotic resistance in patients undergoing serial prostate biopsies: risk factors and impact on clinical outcomes

    Cassra B. Clark, Jay D. Raman
    Canadian Journal of Urology, Vol.31, No.1, pp. 11775-11776, 2024
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    ARTICLE

    Grant funding among underrepresented minority and women urologists at academic institutions

    Simon White1, David Tella1, Bahrom Ostad1, David Barquin2, Caleigh Smith1,Rebecca King3, Kirsten L. Greene1, Tracy Downs1, Nora G. Kern1
    Canadian Journal of Urology, Vol.31, No.1, pp. 11777-11783, 2024
    Abstract Introduction: Grant funding to Urology has decreased over the last decade. Documented lack of gender and race diversity at the faculty level raises concerns for funding disparities. This study sought to characterize disparities based upon race and gender in National Institutes of Health (NIH) funding data to Urologic faculty.
    Methods and materials: Data from 145 ACGME accredited Urology residency programs incorporating faculty gender and underrepresented in medicine (URiM) status was utilized. The NIH Research Portfolio Online Report Tool was queried between 1985 and 2023 for grants related to current Urology faculty. URiM status, gender, years of practice,… More >

  • Open AccessOpen Access

    ARTICLE

    Partial gland ablation with high intensity focal ultrasound impact on genito-urinary function and quality of life: our initial experience

    Ioana Fugaru1, David Bouhadana1, Gautier Marcq2,3, Joseph Moryousef4, Alexis Rompré-Brodeur1, Andrew Meng4, Oleg Loutochin1, George Loutochin1, Maurice Anidjar1, Frank Bladou5, Rafael Sanchez-Salas1
    Canadian Journal of Urology, Vol.31, No.1, pp. 11784-11793, 2024
    Abstract Introduction: Partial gland ablation (PGA) using high intensity focal ultrasound (HIFU) is an alternative to active surveillance for low to intermediate risk localized prostate cancer. This pilot study assessed quality of life (QoL) outcomes during the implementation of PGA HIFU at our institution.
    Materials and methods: We prospectively enrolled 25 men with a diagnosis of localized low/intermediate risk prostate cancer who elected to undergo PGA-HIFU in a pilot study at our institution between 2013 and 2016. Patients underwent pre-treatment mpMRI and transrectal ultrasound-guided biopsies. The primary endpoints were impact on patient-reported functional outcomes (erectile, urinary function, QoL)… More >

  • Open AccessOpen Access

    ARTICLE

    A combined MRI-PSAD risk stratification system for prioritizing prostate biopsies

    Noam Bar-Yaakov1,2, Ziv Savin1,2, Ibrahim Fahoum2,3, Sophie Barnes2,4, Yuval Bar-Yosef1,2, Ofer Yossepowitch1,2, Gal Keren-Paz1,2, Roy Mano1,2
    Canadian Journal of Urology, Vol.31, No.1, pp. 11793-11801, 2024
    Abstract Introduction: Prostate cancer screening with PSA is associated with low specificity; furthermore, little is known about the optimal timing of biopsy. We aimed to evaluate whether a risk classification system combining PSA density (PSAD) and mpMRI can predict clinically significant cancer and determine biopsy timing.
    Materials and methods: We reviewed the medical records of 256 men with a PI-RADS ≥ 3 lesion on mpMRI who underwent transperineal targeted and systematic biopsies of the prostate between 2017-2019. Patients were stratified into three risk groups based on PSAD and mpMRI findings.
    The study endpoint was clinically significant prostate cancer (CSPC).… More >

  • Open AccessOpen Access

    HOW I DO IT

    Use of the Schelin Catheter for transurethral intraprostatic anesthesia prior to Rez ūm treatment

    Aalya Hamouda1, Ahmed Ibrahim2, Nicholas Corsi3, Giampaolo Siena4,Dean S. Elterman5, Bilal Chughtai6, Naeem Bhojani2, Francesco Sessa4, Anna Rivetti4, Silvia Secco7, Kevin C. Zorn2,8
    Canadian Journal of Urology, Vol.31, No.1, pp. 11802-11808, 2024
    Abstract Minimally invasive surgery techniques (MIST) have become newly adopted in urological care. Given this, new analgesic techniques are important in optimizing patient outcomes and resource management. Rez ūm treatment (RT) for BPH has emerged as a new MIST with excellent patient outcomes, including improving quality of life (QoL) and International Prostate Symptom Scores (IPSSs), while also preserving sexual function. Currently, the standard analgesic approach for RT involves a peri prostatic nerve block (PNB) using a transrectal ultrasound (TRUS) or systemic sedation anesthesia. The TRUS approach is invasive, uncomfortable, and holds a risk of infection. Additionally,… More >

  • Open AccessOpen Access

    RESIDENT’S CORNER

    Mullerianosis of the urinary bladder: a case report

    Grace Helene Wegrzyn1, Melissa Kilianek2, Suzanne Iwaz3, Patricia Vidal1, Ryan W. Dobbs1
    Canadian Journal of Urology, Vol.31, No.1, pp. 11809-11812, 2024
    Abstract Mullerianosis is a rare, complex, benign tumor most commonly found in the bladder and often mistaken for a neoplastic lesion. Herein, we report a case of mullerianosis in a 65-year-old woman who presented with an incidental 2 cm bladder mass found on cross-sectional imaging. A mixed cystic and solid tumor was identified on cystoscopy and a transurethral resection of the suspected tumor was performed with histopathology confirming a final diagnosis of mullerianosis. While an unusual diagnosis, mullerianosis of the urinary bladder needs to be correctly identified to provide appropriate treatment and avoid misdiagnosis. More >

  • Open AccessOpen Access

    BOOK REVIEW

    Techniques in Percutaneous Renal Stone Surgery

    Subodh R. Shivde
    Canadian Journal of Urology, Vol.31, No.1, pp. 11813-11813, 2024
    Abstract This article has no abstract. More >

Per Page:

Share Link